Cartesian Therapeutics (RNAC) EBT Margin (QoQ) (2015 - 2026)

Cartesian Therapeutics (RNAC) EBT Margin (QoQ) (2015 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Cartesian Therapeutics 226.07 Mn 226.07 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -2.62 Mn
Mar 31, 2025 -486,043.00
Jun 30, 2024 37,145.00
Mar 31, 2024 195,318.00
Dec 31, 2023 -224,171.00
Sep 30, 2023 20,543.00
Jun 30, 2023 -1,988.00
Mar 31, 2023 -35,634.00
Dec 31, 2022 7,304.00
Sep 30, 2022 -7,366.00
Jun 30, 2022 435.00
Mar 31, 2022 -1,169.00
Dec 31, 2021 4,980.00
Sep 30, 2021 -715.00
Jun 30, 2021 6,991.00
Mar 31, 2021 5,802.00
Dec 31, 2020 8,016.00
Jun 30, 2019 -545,385.00
Mar 31, 2019 -12.08 Mn
Dec 31, 2017 -5.94 Mn